Bobur Mirzayev
Research Subjects
Bobur Mirzayev has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Amit Ohja
San Jos State University,San Jose,CA
1 shared publication- Jakhongir Shaturaev
Tashkent State University of Economics
1 shared publication Kishore Ande
California State University Northridge,Northridge,CA
1 shared publicationMirjalol Ismoilov Ruziboy Ugli
Urgench State University named after Abu Rayhan Biruni,Department of Transport systems,Urgench,Uzbekistan
1 shared publicationPankaj Kumar
Amity University,Kolkata,India
1 shared publicationSaideep Nakka
University of North Texas,Texas,United States
1 shared publication
Latest Publications
- 22 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Generative AI and Cloud Data Engineering for Business Intelligence
- 22 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Generative AI and Cloud Data Engineering for Business Intelligence
- 22 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Quality Systems for Pharma: CAPA Optimisation and Leadership in Compliance
Corrective and Preventive Action (CAPM) systems form the foundation of the pharmaceutical quality because they ensure compliance, product integrity, and safety of patients. The strategic CAPA integration revealed in this review pertains to the leadership accountability, digital transformation, and organizational culture. Systemic changes are needed in problems that are chronic such as ineffective root cause analysis, slow closure and half hearted correction actions. The effective CAPA links quality data, decision tools and corrections in-process and the leadership and good quality culture is important enablers. It is complemented by AI-powered prediction analytics, globalized CAPM standards, and culture-based performance indicators, making CAPM become more of a quality excellence and source of innovation throughout the lifecycle of the pharmaceutical industry.
- 22 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Quality Systems for Pharma: CAPA Optimisation and Leadership in Compliance
Corrective and Preventive Action (CAPM) systems form the foundation of the pharmaceutical quality because they ensure compliance, product integrity, and safety of patients. The strategic CAPA integration revealed in this review pertains to the leadership accountability, digital transformation, and organizational culture. Systemic changes are needed in problems that are chronic such as ineffective root cause analysis, slow closure and half hearted correction actions. The effective CAPA links quality data, decision tools and corrections in-process and the leadership and good quality culture is important enablers. It is complemented by AI-powered prediction analytics, globalized CAPM standards, and culture-based performance indicators, making CAPM become more of a quality excellence and source of innovation throughout the lifecycle of the pharmaceutical industry.